Changes in CT morphology can be an independent response marker for patients receiving regorafenib for colorectal liver metastases: retrospective pilot study.

Ozaki, Yukinori; Shindoh, Junichi; Gonoi, Wataru; Nishioka, Yujiro; Kondoh, Chihiro; Tanabe, Yuko; Matoba, Shuichiro; Kuroyanagi, Hiroya; Hashimoto, Masaji; Takano, Toshimi

Ozaki, Yukinori; Shindoh, Junichi; Gonoi, Wataru; Nishioka, Yujiro; Kondoh, Chihiro; Tanabe, Yuko; Matoba, Shuichiro; Kuroyanagi, Hiroya; Hashimoto, Masaji; Takano, Toshimi.

Afiliação

Ozaki Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Shindoh J; Hepatobiliary-pancreatic Surgery Division, Department of Digestive Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. shindou-tky@umin.ac.jp.
Gonoi W; Okinaka Memorial Institute for Medical Disease, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. shindou-tky@umin.ac.jp.
Nishioka Y; Department of Radiology, University of Tokyo Hospital, 7-3-1 Hongou, Bunkyou-ku, Tokyo, 113-8655, Japan.
Kondoh C; Hepatobiliary-pancreatic Surgery Division, Department of Digestive Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Tanabe Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Matoba S; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Kuroyanagi H; Colorectal Surgery Division, Department of Digestive Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Hashimoto M; Colorectal Surgery Division, Department of Digestive Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
Takano T; Hepatobiliary-pancreatic Surgery Division, Department of Digestive Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.

BMC Cancer ; 18(1): 138, 2018 02 05.

Article em En | MEDLINE | ID: mdl-29402244

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Neoplasias Colorretais/tratamento farmacológico; Neoplasias Hepáticas/tratamento farmacológico; Compostos de Fenilureia/uso terapêutico; Piridinas/uso terapêutico; Adulto; Idoso; Idoso de 80 Anos ou mais; Neoplasias Colorretais/diagnóstico por imagem; Neoplasias Colorretais/patologia; Intervalo Livre de Doença; Feminino; Fluoruracila/administração & dosagem; Humanos; Neoplasias Hepáticas/diagnóstico por imagem; Neoplasias Hepáticas/secundário; Masculino; Pessoa de Meia-Idade; Compostos de Fenilureia/administração & dosagem; Projetos Piloto; Prognóstico; Piridinas/administração & dosagem; Estudos Retrospectivos; Tomografia Computadorizada por Raios X; Resultado do Tratamento

Palavras-chave

Chemotherapy; Colorectal liver metastases; Morphologic response; RECIST; Regorafenib

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Piridinas / Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Hepáticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google